Newsletter

Selected as an excellent corporation for KOSPI disclosure by 11 companies including Dong-A ST and Sambaro

(Counterclockwise from left in the front row) Lim Jae-joon, head of the Korea Exchange Securities Market, Kim Du-man, vice president of Ssangyong C&E, Yoo Kwang-bok, Samsung Heavy Industries’ vice president, Lee Seong-geun, executive director of Dong-A ST Deputy Head of Securities Market Division, Kyu-Young Jang, E-Mart Finance Manager, Yeon-Sung Lee, Team Leader of Hyundai Home Shopping, Jin-Ho Cho, Executive Vice President of Hyundai Heavy Industries Holdings, Ji-Yoon Lee, Vice President of Kakao, In-Sik Yoon, Vice President of Hanwha Systems, Do-Young Huh, Executive Vice President of Samsung Biologics (Photo: Korea Exchange)

11 domestic companies including Dong-A ST (CEO Eom Dae-shik, Wang Jong-hyun) and Samsung Biologics (CEO Lim Jon Jong-bo) were selected as corporations with excellent disclosures in the stock market by the Korea Exchange.

The Korea Exchange (Chairman Byung-doo Sohn) selected 11 domestic companies in Seoul on the 10th and awarded them as “Excellent stock market disclosure in 2021”. Eight companies including Dong-A ST, Mirae Asset, Hyundai Heavy Industries Holdings, E-Mart, Grand Korea Leisure, Hyundai Home Shopping, Ssangyong C&E, and Samsung Heavy Industries were selected as the corporations with excellent public disclosure. In addition, three companies, △Samsung Biologics △Kakao △Hanwha Systems, were selected as the corporations with excellent English disclosure.

The organizer said, “Based on the disclosure performance in 2021, 8 companies with excellent disclosure and 3 companies with excellent disclosure in English were selected through the first quantitative evaluation and the second qualitative evaluation process.”

Preferential benefits include △exemption of annual fee and listing fee for one year after selection △exemption from designation of infidelity disclosure corporation only once for three years △exemption from annual training.

Among pharmaceutical companies, two selected companies are Dong-A ST and Samsung Biologics.

(Picture right) Dong-A ST Executive Vice President Lee Seong-geun is being awarded a plaque of commendation for 'Excellent Public Disclosure Corporation'.  (Photo: Dong-A ST)
(Picture right) Dong-A ST Executive Vice President Lee Seong-geun is being awarded a plaque of commendation for ‘Excellent Public Disclosure Corporation’. (Photo: Dong-A ST)

The main reasons for selection are: Excellent public disclosure corporationselected as Dong-A STIn order to manage disclosure risk, it always shared work data with related departments, constantly monitored the enactment and revision of disclosure-related laws and regulations, and regularized in-house disclosure education such as guidelines for comprehensive pharmaceutical and biotechnology disclosures received good reviews.

According to Dong-A ST, the company complied with and implemented the laws and disclosure regulations on the capital market and financial investment business, and endeavored to disclose disclosures to external stakeholders such as shareholders and investors in a timely and transparent manner. In addition, the infrastructure for integrated management of disclosure information and employee training for the importance of disclosure are being operated.



In addition, to enhance transparency in the governance structure and enhance shareholder value, the board of directors, the internal decision-making body, consists of a majority of outside directors, and the CEO and the chairperson of the board are separated, and an outside director serves as the chairperson. The Evaluation and Compensation Committee and Audit Committee, which are committees within the BOD, are all composed of outside directors, and more than two-thirds of the Outside Director Candidate Recommendation Committee is composed of outside directors.

A Dong-A ST official said, “As a result of our efforts to improve management transparency and protect shareholders and investors, we were selected as a corporation with excellent disclosures in the stock market.” I will do my best to become Dong-A ST.”

(Picture right) Samsung Biologics Managing Director Do-young Huh is receiving a plaque of commendation for 'Excellent English Disclosure Corporation'.  (Photo: Samsung Biologics)
(Picture right) Samsung Biologics Managing Director Do-young Huh is receiving a plaque of commendation for ‘Excellent English Disclosure Corporation’. (Photo: Samsung Biologics)

Excellent English disclosure corporationselected as Samsung Biologicswas announced as the main reason for its selection because it continued to communicate with domestic and foreign investors to provide prompt and accurate disclosure information to overseas investors.

According to Samsung ByLogics, the company submitted a total of 126 disclosures in English from 2017 to 2022, and the status was disclosed in the Corporate Governance Report every May.

In particular, it focused on providing practical information by disclosing information in English on items that are required for ad hoc disclosure and voluntary disclosure related to performance, which are highly useful to foreign investors. In addition, the official website continues to publish business reports and sales reports in English.

CEO John Lim said, “As a global CDMO company with the world’s largest biopharmaceutical production facility, we are focusing on providing useful corporate information to customers and investors around the world. “He said.

Lim Jae-joon, head of the Korea Exchange’s stock market division, said, “I would like to express my appreciation for the efforts of an excellent disclosure corporation that established an efficient disclosure process based on a systematic internal control system and actively communicated with investors.” We ask that you make efforts to improve the security system and, in particular, protect individual investors who are in the blind spot of information.”